Jump to content
  • Welcome!

    Register and log in easily with Twitter or Google accounts!

    Or simply create a new Huddle account. 

    Members receive fewer ads , access our dark theme, and the ability to join the discussion!

     

Vinny Trocheck and His Future


Anybodyhome
 Share

Recommended Posts

https://thehockeywriters.com/hurricanes-tough-contract-decision-vincent-trocheck/

Since coming to the Carolina Hurricanes via a trade with the Florida Panthers back in February of 2020, Vincent Trocheck has emerged as a key piece of the team’s identity. He’s slotted in exclusively as the second-line center since his arrival, which pushed down Jordan Staal to his rightful position on the third line – which has, in turn, been a key to his resurgence. With Sebastian Aho centering the top line, this trio has given the team one of the strongest center-ice groupings in the NHL.

Despite the success, many factors go into the business side of things in this league — and that’s where things begin to complicate surrounding Trocheck. He’s set to be an unrestricted free agent on July 1, 2022, and will be 29 when his next contract kicks in. The Dougie Hamilton negotiations this past summer showed that the Hurricanes aren’t particularly interested in committed big-money contracts to aging players. With Troheck’s injury history and style of play, it’s difficult to see the team breaking the trend for him.

Trocheck’s Overall Impact

Even though it currently seems like a long shot that Trocheck will get the kind of deal he wants in Carolina, it’s important to note how important he is to the current make-up of the team’s roster and how that could factor in upcoming negotiations. He’s been a seamless fit in his role thus far — a role that the Hurricanes had been searching for nearly a decade to fill. You can argue that his stability as the second-line center has also stabilized the entire depth chart at the position and has brought out the best in other players (like Staal).

Things get even more complicated when you consider the type of production the team will need to replace, should they move on from him. Since joining the team, he’s posted 61 points across 77 games — and has developed some legitimate chemistry with youngsters like Martin Necas.

The fact that head coach Rod Brind’Amour also trusts him enough to deploy him in all situations really needs to be considered. He averages well over three minutes per game on the power play, and he’s one of the team’s most relied upon forwards in ice-time per game (17:06). He also features regularly on the penalty kill and has had fantastic results — in 23 games, the Hurricanes have not surrendered a single shorthanded goal with Trocheck on the ice. Considering he averages 1:24 per game on that unit, his suppression rates are very impressive, and they speak volumes as to why Brind’Amour leans on him so often.

Kotkaniemi Among Many Internal Replacement Options

When you’re talking about potentially replacing a player who’s such a vital part of a team’s identity, you better be damn sure that there are adequate options to fill that role in place. Thanks to first-class drafting and development by the Hurricanes’ organization, they’ve amassed numerous potential options that may be a fit for that role in a year from now. Of course, it must be remembered that none of what they have internally has proven they can effectively play second-line minutes in the NHL. The team would be taking the “trial by fire” approach — which has both upsides and downsides.

The most logical option as far as replacements go – as of this moment – would be Jesperi Kotkaniemi, who’s begun settling in quite nicely in Raleigh. The team had intended to move him to the wing as he transitioned into the system, but mediocre results in the process have seen him move back to center. He’s been much more effective in that role — which is expected — as center is his natural position, and that’s where he played with the Montreal Canadiens. His production through 23 games is a down-grade from that of Trocheck’s, but he’s on pace to score 21 goals and has played exclusively in a bottom-six slot.

With Kotkaniemi, you’d imagine that elevated minutes and playing alongside more skilled linemates would translate to an uptick in production, which is certainly plausible. He’s far younger than Trocheck, he has room to grow and could theoretically have more upside if things go to plan. On the other hand, he’ll be drawing much tougher assignments and being allocated heavier minutes. There’s sure to be growing pains and a learning curve for him to adapt to a much-expanded role in the system, and he’ll have his work cut out for him to earn the same trust that Trocheck currently has.

The major question will be how comfortable the Hurricanes’ staff would be to go with a much more inexperienced option. Kotkaniemi is a huge dip from Trocheck in that regard, but the other potential options are even further down the chart. Jack Drury and Jamieson Rees are both top prospects who impressed in training camp and have had strong developmental seasons — but they’re both first-year pros and adapting to the rigors of men’s hockey. Ryan Suzuki is another young center with a bright future, but injuries continue to limit the acceleration of his development.

While all three of Rees, Drury, and Suzuki figure to be part of the Hurricanes’ future, it’s hard to sit here today and realistically pencil any of them in as a legitimate Trocheck replacement in less than a year from now. They’re all very talented and could turn the switch on at some point. Still, it’s difficult to imagine the team being comfortable with such inexperienced options in a major role — especially if they plan to be a Stanley Cup contender again next season. For now, Kotkaniemi would be the clubhouse leader. He has the skill, experience, and a comparable style to Trocheck — he has all the tools, but can he put them all together?

Trocheck Likely to Cash In

In the world of pro sports, money always does the talking — and that’s what it’ll boil down to for Trocheck. He’ll be 29 years old when his next contract kicks in, so it’s fair to say that this could be his final major opportunity to cash in on a long-term deal. His production through 23 games has him on pace for a 57-point season, which is a solid output from a second-line center and even more valuable when considering his relentless forechecking and penalty-kill success.

Safe to say, I think there’d be a rather large market for Trocheck should he go to free agency. Players of his caliber don’t become available all too often, and NHL teams have shown a commitment to building down the middle. I’d assume that his strong scoring pace, combined with the team’s reluctance to commit long-term contracts to aging players, makes it a very likely possibility that he’ll head to the open market in the summer of 2022. If he continues to produce at this rate, I’d imagine that he’ll price himself out of the Canes’ comfort zone – similar to the Hamilton contract.

Recapping the Hurricanes’ Options

The good news with this negotiation is that the ball figures to be in the Hurricanes’ court. They’ve emerged into a legitimate Stanley Cup contender and are becoming a destination place to play — in a great city with a great fanbase and organization. If Trocheck’s contract demands are reasonable and the team is willing to commit to that, there’s a lot of reason for optimism that he’d choose to re-sign in Carolina rather than start fresh elsewhere. He’s been a seamless fit on the ice, he seems to be a popular teammate, and the fanbase has grown attached to him.

On the other hand, should Trocheck opt to head to the market and sign elsewhere, the Hurricanes would obviously be OK with the move, and at that point, and would have their replacement options in mind. They could opt to use that freed-up cap space to bring in a replacement from outside the organization, or they could turn internally towards their youth and roll with Kotkaniemi or a Drury/Rees type — if they mature. Regardless, General Manager Don Waddell and Co. have earned the benefit of the doubt that they’ll do what’s best for the team with the long-term vision in mind and continue to have this group on the right path moving forward.

  • Flames 1
Link to comment
Share on other sites

I actually think we manage to keep him for around $6M per year.

Dundon values offense more than defense. After all, he stated that we’d never draft a defenseman in the first round while he is owner. Not to mention, the Canes value the center position more than any other position as they are constantly drafting centers.

I think Trocheck is resigned as he’s the perfect 2C. Additionally, I think the thought was that KK could make Trocheck expendable but that’s obviously not the case. Couple that with the fact that Staal is on his last contract with the Canes, I believe Trocheck is resigned to a $6Mx5 and he makes it in the fourth year of his deal before he is traded.

For the next couple of years I project that we stick with Aho/Trocheck/Staal/KK or Drury

I could see the future looking like Aho/Jarvis/KK or Rees/Drury

  • Pie 1
Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

 Share


  • PMH4OWPW7JD2TDGWZKTOYL2T3E.jpg

  • Topics

  • Posts

    • For me to judge I look at it by group: QB - Improved most likely RB - Improved most likely (rookie upside) WR - Greatly improved (rookie upside) TE - Improved most likely (rookie upside) OL - Greatly improved DL - Slight downgrade (maybe?  Robinson + Wonnum + Clowney < Burns???  Could be equal or better) LB - Slight downgrade (different players - rookie upside) CB - Slight downgrade (rookie upside) S - Push Coaching - Greatly improved To me I expect us to be significantly better overall - but significant over last year means 5-6 wins.  
    • In a world where chronic pain can be debilitating, GDR Labs CONOCB2 emerges as a beacon of hope, offering a natural solution to ease pain without the side effects associated with traditional painkillers. Let’s delve deep into this revolutionary product and explore its benefits, ingredients, pricing, and more. What is GDR Labs CONOCB2? GDR Labs CONOCB2 is a groundbreaking pain relief formula that harnesses the power of the natural alkaloid Conolidine, derived from the crepe jasmine plant. This compound has been scientifically proven to provide pain relief comparable to morphine without the adverse effects typically associated with traditional opioids. Does GDR Labs CONOCB2 Work? Based on extensive research and clinical trials, GDR Labs CONOCB2 has demonstrated remarkable efficacy in alleviating various types of pain, making it a game-changer in the world of pain management. The unique pain relief mechanism of Conolidine sets it apart as a safe and effective alternative to conventional pain medications. Try GDR Labs CONOCB2 now and experience the difference! What are the Ingredients in GDR Labs CONOCB2? Conolidine: The key alkaloid extracted from the crepe jasmine plant, renowned for its potent pain-relieving properties without side effects. Other Natural Extracts: Complementary ingredients carefully selected to enhance the overall efficacy of the formula. GDR Labs CONOCB2 Benefits Significant pain relief without side effects Natural and drug-free solution Clinically validated and backed by years of research Suitable for individuals of all ages To enjoy the benefits of GDR Labs CONOCB2, click here to order your supply now! What is the Price of GDR Labs CONOCB2? 1 Bottle CONOCB2 + Free Shipping Price: $29 (Save $91) 3 Bottles CONOCB2 + Free Shipping Price: $87 (Save $273) 6 Bottles CONOCB2 + Free Shipping Price: $174 (Save $546) Order GDR Labs CONOCB2 Right Here At The Best Prices!! Money Back Guarantee Since 2011, GDR Labs has stood behind its products with a robust 100% Money-Back Guarantee. If you are not satisfied with the product for any reason, you have 90 days to return it for a full refund. This extended period allows you to experience the full benefits of the product before making a decision. Secure Purchase Rest easy knowing that your purchase is secure with GDR Labs. Complete your order and enjoy the assurance of a safe and satisfying transaction. Are There Side Effects to GDR Labs CONOCB2? GDR Labs CONOCB2 is formulated with natural ingredients and has undergone rigorous testing to ensure safety and efficacy. As a result, there have been no reported side effects associated with the use of this product. Who Makes GDR Labs CONOCB2? GDR Labs is the innovative company behind the development of CONOCB2, led by medical scientist Clint Winters. With a passion for natural pain relief solutions, GDR Labs is committed to providing effective alternatives to traditional pain medications. Does GDR Labs CONOCB2 Really Work? The extensive scientific research and clinical trials conducted on GDR Labs CONOCB2 provide compelling evidence of its effectiveness in combating chronic pain. Thousands of satisfied users have experienced life-changing relief through the use of this revolutionary product. Don’t buy GDR Labs CONOCB2 without reading the reviews >>> Is GDR Labs CONOCB2 a Scam? Rest assured, GDR Labs CONOCB2 is a legitimate and scientifically-backed pain relief solution developed by a reputable company. The transparency of the research and the positive testimonials from users underscore the authenticity of this innovative product. Customer Testimonials Sarah from New York: “GDR Labs CONOCB2 has been a game-changer for my chronic back pain. I can finally enjoy activities I love without relying on harmful medications.” John from California: “After years of searching for a natural pain relief solution, I am grateful to have found GDR Labs CONOCB2. It truly lives up to its promises.” Emily from Texas: “I was skeptical at first, but GDR Labs CONOCB2 exceeded my expectations. It has given me a new lease on life, free from pain and side effects.” Is GDR Labs CONOCB2 FDA Approved? While GDR Labs CONOCB2 may not be FDA-approved, it is based on natural ingredients and has undergone extensive clinical testing to ensure safety and efficacy. Where to Buy GDR Labs CONOCB2? To purchase GDR Labs CONOCB2 and experience its transformative benefits, visit their official website here and place your order today. Conclusion for GDR Labs CONOCB2 GDR Labs CONOCB2 emerges as a groundbreaking pain relief innovation, presenting a natural and side effect-free remedy for individuals grappling with chronic pain. Backed by rigorous scientific research and compelling user feedback, this product brings a promising solution to those in search of safe and efficient pain management alternatives. The formula’s ability to deliver potent pain relief without incurring adverse effects marks a significant advancement in the realm of pain management. By offering a holistic and effective approach to addressing pain, GDR Labs CONOCB2 holds the potential to revolutionize the lives of individuals struggling with persistent discomfort. Its innovative nature and proven efficacy position it as a beacon of hope for individuals seeking a reliable and sustainable means of alleviating pain. Through its commitment to providing a natural, drug-free solution, GDR Labs CONOCB2 paves the way for a new era in pain relief mechanisms, promising relief without compromise.    
×
×
  • Create New...